CTIC logo

CTI BioPharma (CTIC) Operating Expenses

Annual Operating Expenses

$130.23 M
+$34.90 M+36.61%

December 31, 2022

Summary

Performance

1-Year Change

+36.61%

3-Year Change

+201.03%

5-Year Change

+102.53%

15-Year Change

+102.53%

CTIC Operating Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$181.94 M
CTIC annual total operating expenses is currently -28.42% below its historical high of $181.94 million

3-Year Low

$95.33 M
CTIC annual total operating expenses is currently +36.61% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
CTIC previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
CTIC next annual earnings announcement has not yet been scheduled

OtherCTICexpensesmetrics:

Annual Total Expenses

$133.75 M
CTIC annual total expenses is $133.75 million

Annual Interest Expense

$14.13 M
CTIC annual interest expense is $14.13 million

Annual Income Tax

-
CTIC annual income tax value is unknown

Annual Cost Of Goods Sold

$3.51 M
CTIC annual cost of goods sold is $3.51 million

Quarterly Operating Expenses

$32.12 M
-$1.39 M-4.14%

March 31, 2023

Summary

Performance

3-Month Change

-4.14%

1-Year Change

-13.45%

3-Year Change

+169.25%

5-Year Change

+111.59%

CTIC Quarterly Operating Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$56.87 M
CTIC quarterly total operating expenses is currently -43.51% below its historical high of $56.87 million

3-Year Low

$29.31 M
CTIC quarterly total operating expenses is currently +9.61% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2023
CTIC previous earnings announcement was published on Mar 31, 2023

Next Quarterly Earnings Report Date

N/A
CTIC next earnings announcement has not yet been scheduled

OtherCTICexpensesmetrics:

Quarterly Total Expenses

$33.35 M
CTIC quarterly total expenses is $33.35 million

Quarterly Interest Expense

$5.05 M
CTIC quarterly interest expense is $5.05 million

Quarterly Income Tax

-
CTIC quarterly income tax value is unknown

Quarterly Cost Of Goods Sold

$1.22 M
CTIC quarterly cost of goods sold is $1.22 million

Operating Expenses Formula

Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses

Annual Operating Expenses

$130.23 M
CTIC annual total operating expenses is $130.23 million

Annual SGA

$84.83 M
CTIC annual SGA is $84.83 million

Annual D&A

$1.95 M
CTIC annual depreciation & amortization is $1.95 million

CTIC Operating Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+36.6%-13.4%
3 y3 years+201.0%+169.3%
5 y5 years+102.5%+111.6%

CTIC Operating Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high-26.8%-13.5%-8.8%
5 y5-yearat high-66.8%-13.5%-70.5%
alltimeall time-28.4%-80.5%-43.5%-146.0%

CTI BioPharma Operating Expenses History

DateAnnualQuarterly
Mar 2023
-
$32.12 M(-4.1%)
Dec 2022
$130.23 M(+36.6%)
$33.51 M(+14.3%)
Sep 2022
-
$29.31 M(-3.3%)
Jun 2022
-
$30.30 M(-18.4%)
Mar 2022
-
$37.12 M(+4.9%)
Dec 2021
$95.33 M(+99.6%)
$35.38 M(+51.3%)
Sep 2021
-
$23.38 M(+19.9%)
Jun 2021
-
$19.51 M(+14.3%)
Mar 2021
-
$17.07 M(+15.4%)
Dec 2020
$47.77 M(+10.4%)
$14.80 M(+33.9%)
Sep 2020
-
$11.05 M(+10.5%)
Jun 2020
-
$10.00 M(-16.2%)
Mar 2020
-
$11.93 M(+25.9%)
Dec 2019
$43.26 M(-26.1%)
$9.47 M(-21.1%)
Sep 2019
-
$12.00 M(+5.2%)
Jun 2019
-
$11.41 M(+9.9%)
Mar 2019
-
$10.38 M(-21.6%)
Dec 2018
$58.53 M(-9.0%)
$13.24 M(-14.5%)
Sep 2018
-
$15.49 M(+6.0%)
Jun 2018
-
$14.61 M(-3.7%)
Mar 2018
-
$15.18 M(+7.8%)
Dec 2017
$64.30 M(-38.9%)
$14.08 M(+5.1%)
Sep 2017
-
$13.40 M(-20.6%)
Jun 2017
-
$16.88 M(-15.4%)
Mar 2017
-
$19.94 M(+44.2%)
Dec 2016
$105.19 M(-19.6%)
$13.83 M(-58.0%)
Sep 2016
-
$32.93 M(+25.4%)
Jun 2016
-
$26.27 M(-18.3%)
Mar 2016
-
$32.16 M(-12.6%)
Dec 2015
$130.84 M(-10.0%)
$36.79 M(+14.7%)
Sep 2015
-
$32.09 M(+0.4%)
Jun 2015
-
$31.94 M(+6.4%)
Mar 2015
-
$30.02 M(-47.2%)
Dec 2014
$145.41 M(+91.2%)
$56.87 M(+78.8%)
Sep 2014
-
$31.81 M(+14.4%)
Jun 2014
-
$27.81 M(-3.9%)
Mar 2014
-
$28.93 M(+27.6%)
Dec 2013
$76.07 M(-24.4%)
$22.67 M(+43.7%)
Sep 2013
-
$15.77 M(-13.0%)
Jun 2013
-
$18.12 M(-7.1%)
Mar 2013
-
$19.50 M(+6.3%)
Dec 2012
$100.55 M(+37.4%)
$18.34 M(+24.6%)
Sep 2012
-
$14.71 M(-70.2%)
Jun 2012
-
$49.40 M(+173.0%)
Mar 2012
-
$18.10 M(-13.5%)
Dec 2011
$73.19 M(-6.9%)
$20.91 M(+36.8%)
Sep 2011
-
$15.29 M(-9.6%)
Jun 2011
-
$16.92 M(-15.7%)
Mar 2011
-
$20.07 M(+1.2%)
Dec 2010
$78.58 M(-10.6%)
$19.82 M(+52.6%)
Sep 2010
-
$12.99 M(-35.0%)
Jun 2010
-
$19.98 M(-22.5%)
Mar 2010
-
$25.78 M(-1.0%)
DateAnnualQuarterly
Dec 2009
$87.90 M(-7.4%)
$26.03 M(-4.5%)
Sep 2009
-
$27.27 M(+52.3%)
Jun 2009
-
$17.90 M(+6.4%)
Mar 2009
-
$16.83 M(-14.9%)
Dec 2008
$94.88 M(-12.4%)
$19.77 M(+0.0%)
Sep 2008
-
$19.77 M(-29.2%)
Jun 2008
-
$27.91 M(+1.6%)
Mar 2008
-
$27.46 M(-15.9%)
Dec 2007
$108.25 M(+10.4%)
$32.65 M(+18.0%)
Sep 2007
-
$27.66 M(+13.7%)
Jun 2007
-
$24.32 M(+2.9%)
Mar 2007
-
$23.62 M(+0.4%)
Dec 2006
$98.09 M(+62.1%)
$23.53 M(-2.1%)
Sep 2006
-
$24.04 M(+2.0%)
Jun 2006
-
$23.56 M(-11.1%)
Mar 2006
-
$26.52 M(-279.6%)
Dec 2005
$60.53 M(-66.7%)
-$14.76 M(+233.7%)
Sep 2005
-
-$4.42 M(-111.6%)
Jun 2005
-
$38.07 M(-8.6%)
Mar 2005
-
$41.64 M(-14.2%)
Dec 2004
$181.94 M(+24.2%)
$48.53 M(+22.2%)
Sep 2004
-
$39.72 M(-10.0%)
Jun 2004
-
$44.14 M(-10.9%)
Mar 2004
-
$49.55 M(+20.0%)
Dec 2003
$146.51 M(+27.1%)
$41.29 M(+14.4%)
Sep 2003
-
$36.09 M(+2.6%)
Jun 2003
-
$35.17 M(+3.5%)
Mar 2003
-
$33.97 M(+10.4%)
Dec 2002
$115.26 M(+29.0%)
$30.76 M(-6.2%)
Sep 2002
-
$32.79 M(+18.0%)
Jun 2002
-
$27.79 M(+16.1%)
Mar 2002
-
$23.93 M(-27.7%)
Dec 2001
$89.33 M(+58.4%)
$33.09 M(+48.2%)
Sep 2001
-
$22.34 M(+16.5%)
Jun 2001
-
$19.17 M(+30.2%)
Mar 2001
-
$14.73 M(-11.9%)
Dec 2000
$56.38 M(+42.0%)
$16.72 M(+8.4%)
Sep 2000
-
$15.42 M(+22.0%)
Jun 2000
-
$12.64 M(-10.7%)
Mar 2000
-
$14.15 M(+57.2%)
Dec 1999
$39.70 M(-7.0%)
$9.00 M(-18.2%)
Sep 1999
-
$11.00 M(+2.8%)
Jun 1999
-
$10.70 M(+18.9%)
Mar 1999
-
$9.00 M(-25.0%)
Dec 1998
$42.70 M(+9.2%)
$12.00 M(+27.7%)
Sep 1998
-
$9.40 M(-9.6%)
Jun 1998
-
$10.40 M(-3.7%)
Mar 1998
-
$10.80 M(-15.0%)
Dec 1997
$39.10 M(+53.9%)
$12.70 M(+41.1%)
Sep 1997
-
$9.00 M(-2.2%)
Jun 1997
-
$9.20 M(+10.8%)
Mar 1997
-
$8.30 M
Dec 1996
$25.40 M
-

FAQ

  • What is CTI BioPharma annual total operating expenses?
  • What is the all time high annual operating expenses for CTI BioPharma?
  • What is CTI BioPharma annual operating expenses year-on-year change?
  • What is CTI BioPharma quarterly total operating expenses?
  • What is the all time high quarterly operating expenses for CTI BioPharma?
  • What is CTI BioPharma quarterly operating expenses year-on-year change?

What is CTI BioPharma annual total operating expenses?

The current annual operating expenses of CTIC is $130.23 M

What is the all time high annual operating expenses for CTI BioPharma?

CTI BioPharma all-time high annual total operating expenses is $181.94 M

What is CTI BioPharma annual operating expenses year-on-year change?

Over the past year, CTIC annual total operating expenses has changed by +$34.90 M (+36.61%)

What is CTI BioPharma quarterly total operating expenses?

The current quarterly operating expenses of CTIC is $32.12 M

What is the all time high quarterly operating expenses for CTI BioPharma?

CTI BioPharma all-time high quarterly total operating expenses is $56.87 M

What is CTI BioPharma quarterly operating expenses year-on-year change?

Over the past year, CTIC quarterly total operating expenses has changed by -$4.99 M (-13.45%)